Apr 5, 2017
RNAi for Therapeutic -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022
Pune , India - April 5, 2017 /MarketersMedia/ —
RNAi for Therapeutic Industry
Description
Wiseguyreports.Com Adds “RNAi for Therapeutic -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database
The Global RNAi for Therapeutic Consumption Market 2016 Industry Trend and Forecast 2021 is a professional and in-depth study on the current state of the RNAi for Therapeutic market
The report provides a basic overview of the RNAi for Therapeutic industry including definitions, classifications, applications and industry chain structure.
Development policies and plans are discussed as well as manufacturing processes are also analyzed.
Request for Sample Report @ https://www.wiseguyreports.com/sample-request/1026276-global-rnai-for-therapeutic-consumption-market-2016-industry-trend-and-forecast
The report then analyzes the global RNAi for Therapeutic expenses, and the sales segment market is also discussed by product type, applications and region.
The major RNAi for Therapeutic market (including United States, Europe, etc.) is analyzed, data including market size, expenses segment market by product type and applications. Then we forecast the 2016-2025 market size of RNAi for Therapeutic.
The report focuses on global major leading companies providing information such as company profiles, expenses, R&D expenses and contact information.
Finally the marketing, feasibility of new investment projects are assessed and overall research conclusions offered.
With 163 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Leave a Query @ https://www.wiseguyreports.com/enquiry/1026276-global-rnai-for-therapeutic-consumption-market-2016-industry-trend-and-forecast
Table of Contents
1 Industry Overview 1
1.1 Definition and Specifications of RNAi for Therapeutic 1
1.1.1 Definition of RNAi for Therapeutic 1
1.1.2 Mechanism and Development History RNAi for Therapeutic 2
1.2 Classification of RNAi for Therapeutic 2
1.2.1 siRNA 3
1.2.2 miRNA 4
1.2.3 shRNA 5
1.3 Applications of RNAi for Therapeutic 7
1.3.1 Cancer 8
1.3.2 Cardiovascular 8
1.3.3 HBV 9
1.4 Industry Chain Structure of RNAi for Therapeutic 10
1.5 Industry Overview and Major Regions Status of RNAi for Therapeutic 10
1.5.1 Industry Overview of RNAi for Therapeutic 10
1.5.2 Global Major Regions Status of RNAi for Therapeutic 12
1.6 Industry Policy Analysis of RNAi for Therapeutic 12
1.7 Industry News Analysis of RNAi for Therapeutic 13
....
9 Analysis of RNAi for Therapeutic Industry Key Manufacturers 63
9.1 Alnylam Pharmaceuticals 63
9.1.1 Company Profile 63
9.1.2 Research Information 64
9.1.3 Expenses, R&D Expenses and R&D Share 64
9.2 Arbutus Biopharma (Tekmira) 66
9.2.1 Company Profile 66
9.2.2 Research Information 66
9.2.3 Expenses, R&D Expenses and R&D Share 67
9.3 Arrowhead Research 69
9.3.1 Company Profile 69
9.3.2 Research Information 70
9.3.3 Expenses, R&D Expenses and R&D Share 70
9.4 Dicerna Pharmaceuticals 72
9.4.1 Company Profile 72
9.4.2 Research Information 73
9.4.3 Expenses, R&D Expenses and R&D Share 73
9.5 Mirna Therapeutics 75
9.5.1 Company Profile 75
9.5.2 Research Information 76
9.5.3 Expenses, R&D Expenses and R&D Share 76
9.6 Quark Pharmaceuticals 78
9.6.1 Company Profile 78
9.6.2 Research Information 79
9.6.3 Expenses, R&D Expenses and R&D Share 79
9.7 RXi Pharmaceuticals 81
9.7.1 Company Profile 81
9.7.2 Research Information 82
9.7.3 Expenses, R&D Expenses and R&D Share 83
9.8 Silence Therapeutics 84
9.8.1 Company Profile 84
9.8.2 Research Information 85
9.8.3 Expenses, R&D Expenses and R&D Share 86
9.9 Benitec Biopharma 87
9.9.1 Company Profile 87
9.9.2 Research Information 88
9.9.3 Expenses, R&D Expenses and R&D Share 88
9.10 miRagen Therapeutics 90
9.10.1 Company Profile 90
9.10.2 Research Information 91
9.10.3 Expenses, R&D Expenses and R&D Share 92
9.11 Sylentis 93
9.11.1 Company Profile 93
9.11.2 Research Information 94
9.11.3 Expenses, R&D Expenses and R&D Share 95
9.12 Gradalis 96
9.12.1 Company Profile 96
9.12.2 Research Information 97
9.12.3 Expenses, R&D Expenses and R&D Share 97
9.13 Sirnaomics 99
9.13.1 Company Profile 99
9.13.2 Research Information 100
9.13.3 Expenses, R&D Expenses and R&D Share 100
9.14 Silenseed 102
9.14.1 Company Profile 102
9.14.2 Research Information 103
9.14.3 Expenses, R&D Expenses and R&D Share 103
Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1026276
Continued...
Contact Us: [email protected] Ph: +1-646-845-9349 (Us) Ph: +44 208 133 9349 (Uk)
Contact Info:
Name: NORAH TRENT
Email: [email protected]
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028
Phone: +91 841 198 5042
For more information, please visit https://www.wiseguyreports.com/sample-request/1026276-global-rnai-for-therapeutic-consumption-market-2016-industry-trend-and-forecast
Source: MarketersMedia
Release ID: 183646
On the 30th anniversary of the franchise, Pokémon cards are skyrocketing in value — to the point that collecting them can be a viable livelihood.
EU minister Hamish Falconer insists Britain would have some influence on policy as part of a new deal.
It’s illegal in the United States to transport game fowl for fighting. But investigators say breeders are sending birds to the Philippines, where cockfighting is legal and lucrative.
A planned American-led artificial intelligence hub in the Philippines has sparked fierce opposition over concerns about displacement, resources and threats to national sovereignty.
They will soon be free to all Apple TV users and will appear on more than one billion devices that have the app, including Rokus and smart TVs.
Some parents are so desperate for their children to find a job that they've offered to pay their wages, one hairdresser has told the BBC.
Prominent figures in Silicon Valley want to see Jensen Huang reinstalled as Nvidia’s boss. Some in the Trump administration don’t want him to return.
The announcement came after a New York Times investigation about the restrictive contracts of the group NewJeans, signed when its members were 14 to 17.
A Chinese businessman arrived in Panama with money and power. Then he sold a port when his luck turned. Now China wants him sent back.
Phillips was always an underdog in the auction world, but it had ambition to compete with Christie’s and Sotheby’s. Then the economics changed.
The founder of the collapsed FTX crypto exchange, who is serving prison time for fraud, would have made a windfall from a $500 million investment in Anthropic.
Insurance companies are investing billions of their customers’ money into A.I. deals as analysts warn of mounting risks.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.